U.S. Markets closed

Aytu Biopharma, Inc. (AYTU)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.1000-0.1100 (-2.61%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.2100
Bid4.0700 x 800
Ask4.1900 x 800
Day's Range4.0550 - 4.2100
52 Week Range4.0100 - 14.9000
Avg. Volume968,257
Market Cap103.199M
Beta (5Y Monthly)-0.29
PE Ratio (TTM)N/A
EPS (TTM)-3.1000
Earnings DateOct 04, 2021 - Oct 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.25
  • Implied Volatility Surging for Aytu Biopharma (AYTU) Stock Options

    Implied Volatility Surging for Aytu Biopharma (AYTU) Stock Options

    Investors need to pay close attention to Aytu Biopharma (AYTU) stock based on the movements in the options market lately.


    Aytu BioPharma Announces Peer-Reviewed Publication of Clinical Results from Healight(TM) Pilot Study

    Results Indicate That Endotracheal UVA Light Catheter Therapy is Associated with Significant Reduction in SARS-CoV-2 Viral Load and Improvement in Clinical Outcomes in Mechanically Ventilated COVID-19 PatientsENGLEWOOD, CO / ACCESSWIRE / June 28, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced today that data from the first in-human, open label, clinical trial studying the sa

  • 2 “Strong Buy” Stocks Trading at Rock-Bottom Prices

    2 “Strong Buy” Stocks Trading at Rock-Bottom Prices

    We’re halfway through the year, and while the markets have been volatile, investors are having a good time so far. The S&P 500 has gained 11% year-to-date, and the tech-heavy NASDAQ has gained 9%. With the Fed keeping interest rates at historic lows, stocks are offering better rates of return – and they are keeping ahead of inflation, as well. But while the overall markets are up, individual stock performance can and will vary. Which means that in the midst of a general rising trend, it’s still